<DOC>
	<DOCNO>NCT01350687</DOCNO>
	<brief_summary>Pulmonary hypertension new complication describe hemodialysis patient . last year patient treat calcium carbonate orally control serum phosphor . Calcium phosphor deposit pulmonary artery explain phenomenon . The investigator want investigate new phosphor non calcium contain agent hemodialysis patient measure pulmonary pressure .</brief_summary>
	<brief_title>Pulmonary Hypertension Prevention Hemodialysis</brief_title>
	<detailed_description>The investigator measure pulmonary blood pressure treatment new phosphor binder , non calcium containing .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<criteria>Hemodialysis Patients without fistula Heart Disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Calcium Phosphore</keyword>
	<keyword>Renagel</keyword>
</DOC>